ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Vorinostat Combined with Cytarabine and Etoposide in Leukemia (Clinical Cancer Research) Wednesday April 3rd 2013


100) IL-28B Genotype Is Associated with HCC Recurrence with CHC (Clinical Cancer Research) Wednesday April 3rd 2013


101) LOH of HLA Class I Region in GBM (Clinical Cancer Research) Wednesday April 3rd 2013


102) Multistage Vector Delivery of EphA2 siRNA (Clinical Cancer Research) Wednesday April 3rd 2013


103) Anti-CD19 Therapy in Childhood Leukemia Xenografts (Clinical Cancer Research) Wednesday April 3rd 2013


104) The SMAC Mimetic Birinapant Exhibits Potent Antimelanoma Activity (Clinical Cancer Research) Wednesday April 3rd 2013


105) c-Met Mediates Antiangiogenic Therapy Resistance (Clinical Cancer Research) Wednesday April 3rd 2013


106) GDC-0068, a Novel Selective ATP-Competitive Akt Inhibitor (Clinical Cancer Research) Wednesday April 3rd 2013


107) JQ1 Represses Diverse Glioblastoma Tumors (Clinical Cancer Research) Wednesday April 3rd 2013


108) A Preclinical Pediatric Adrenocortical Carcinoma Xenograft Model (Clinical Cancer Research) Wednesday April 3rd 2013


109) Intrinsic Resistance to JAK2 Inhibition in Myelofibrosis (Clinical Cancer Research) Wednesday April 3rd 2013


110) Aurora Kinase A Inhibitor MLN8237 in Bladder Cancer (Clinical Cancer Research) Wednesday April 3rd 2013


111) B4GALT3 Expression in Neuroblastoma (Clinical Cancer Research) Wednesday April 3rd 2013


112) Circulating Galectin-3 Induces Secretion of Metastasis-Promoting Cytokines (Clinical Cancer Research) Wednesday April 3rd 2013


113) GPER Correlates with Increased DDFS in ER-Positive Breast Cancer (Clinical Cancer Research) Wednesday April 3rd 2013


114) CCR8+ Inflammatory Myeloid Cells in Cancer Patients (Clinical Cancer Research) Wednesday April 3rd 2013


115) DLBCL in Elderly Patients (Clinical Cancer Research) Wednesday April 3rd 2013


116) Retinoids in Cancer Prevention and Treatment (Clinical Cancer Research) Wednesday April 3rd 2013


117) PRLR Inhibitors as Novel Anticancer Therapeutics (Clinical Cancer Research) Wednesday April 3rd 2013


118) Application of Molecular Diagnostics to Clinical Practice (Clinical Cancer Research) Wednesday April 3rd 2013


119) Meta-analysis of Tumor Genotyping (Clinical Cancer Research) Wednesday April 3rd 2013


120) c-Met and Glioblastoma Invasion (Clinical Cancer Research) Wednesday April 3rd 2013


121) CD33 SNPs as Markers of GO Response (Clinical Cancer Research) Friday March 15th 2013


122) RNASEL Predicts Prostate Cancer Outcome (Clinical Cancer Research) Friday March 15th 2013


123) CHFR Expression Predicts Taxane Sensitivity (Clinical Cancer Research) Friday March 15th 2013


124) CTC-Based Nomograms in Metastatic Breast Cancer (Clinical Cancer Research) Friday March 15th 2013


125) Biomarkers for Neoadjuvant Ixabepilone in Breast Cancer (Clinical Cancer Research) Friday March 15th 2013


126) A 12-Gene Predictive Signature for NSCLC (Clinical Cancer Research) Friday March 15th 2013


127) GRN1005 for Recurrent Glioma (Clinical Cancer Research) Friday March 15th 2013


128) Phase II Study of Cediranib in HCC (Clinical Cancer Research) Friday March 15th 2013


129) Castration Decreases Ku70 Protein Levels in Prostate Cancer (Clinical Cancer Research) Friday March 15th 2013


130) Bortezomib-Based Secondary Induction and Mobilization in Multiple Myeloma (Clinical Cancer Research) Friday March 15th 2013


131) Reducing the Number of Cells Improves Targeting of Dendritic Cells to Lymph Nodes (Clinical Cancer Research) Friday March 15th 2013


132) Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors (Clinical Cancer Research) Friday March 15th 2013


133) Optimal Number of Target Lesions for mRECIST and EASL (Clinical Cancer Research) Friday March 15th 2013


134) Photoacoustic Imaging of Thyroid Carcinoma (Clinical Cancer Research) Friday March 15th 2013


135) 18F-FDG PET in Thymic Epithelial Tumors (Clinical Cancer Research) Friday March 15th 2013


136) The Role of CD4+ T Cells in Anti-Neu Therapy (Clinical Cancer Research) Friday March 15th 2013


137) Bone Marrow Neutralizes Regulatory T Cells (Clinical Cancer Research) Friday March 15th 2013


138) Sorafenib Transport by OATP1B (Clinical Cancer Research) Friday March 15th 2013


139) Bortezomib and HDACi in Childhood BCP-ALL (Clinical Cancer Research) Friday March 15th 2013


140) Novel c-MET Targeting Strategies in Cancer Therapy (Clinical Cancer Research) Friday March 15th 2013


141) Targeting the Hedgehog Pathway in BCR-ABL1-Positive Leukemia (Clinical Cancer Research) Friday March 15th 2013


142) Functional Analysis of Candidate Ovarian Cancer Driver Genes (Clinical Cancer Research) Friday March 15th 2013


143) HIC1 Modulates Prostate Cancer Progression (Clinical Cancer Research) Friday March 15th 2013


144) MicroRNA-200a Promotes Anoikis Resistance by Targeting YAP1 (Clinical Cancer Research) Friday March 15th 2013


145) Rab25 in Head and Neck Cancer Metastasis (Clinical Cancer Research) Friday March 15th 2013


146) PD-L1 in Ovarian Cancer Promotes Dissemination through CTL Dysfunction (Clinical Cancer Research) Friday March 15th 2013


147) Host Irradiation Metaprofile (Clinical Cancer Research) Friday March 15th 2013


148) HCV-Induced CXCL10 and Liver Cancer (Clinical Cancer Research) Friday March 15th 2013


149) TLR in Cancer Promotion and Therapy (Clinical Cancer Research) Friday March 15th 2013


150) Enzalutamide (Clinical Cancer Research) Friday March 15th 2013


151) Borrowing Information across Subgroups (Clinical Cancer Research) Friday March 15th 2013


152) Impact of European Union Pediatric Medicine Regulation (Clinical Cancer Research) Friday March 15th 2013


153) Modified RECIST (mRECIST) for Hepatocellular Carcinoma (Clinical Cancer Research) Friday March 15th 2013


154) Ponatinib and Vismodegib in BCR-ABL+ ALL (Clinical Cancer Research) Friday March 15th 2013


155) Correction: Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis (Clinical Cancer Research) Sunday March 3rd 2013


156) Tales of How Great Drugs Were Brought Down by a Flawed Rationale--Response (Clinical Cancer Research) Sunday March 3rd 2013


157) Tales of How Great Drugs Were Brought Down by a Flawed Rationale--Letter (Clinical Cancer Research) Sunday March 3rd 2013


158) Tales of How Great Drugs Were Brought Down by a Flawed Rationale--Letter (Clinical Cancer Research) Sunday March 3rd 2013


159) Colon Cancer Mutation: Prognosis/Prediction-Response (Clinical Cancer Research) Sunday March 3rd 2013


160) Colon Cancer Mutation: Prognosis/Prediction-Letter (Clinical Cancer Research) Sunday March 3rd 2013


161) Serum Blood Group A Antibodies as Biomarkers for PROSTVAC-VF (Clinical Cancer Research) Sunday March 3rd 2013


162) VEGFA Gene Amplification in Metastatic Breast Cancer (Clinical Cancer Research) Sunday March 3rd 2013


163) A PK/PD Model of TLS in CLL Patients Receiving Flavopiridol (Clinical Cancer Research) Sunday March 3rd 2013


164) Phase I Dovitinib in Renal Cell Carcinoma (Clinical Cancer Research) Sunday March 3rd 2013


165) Chemoprevention of HNSCC by Targeting EGFR and COX-2 (Clinical Cancer Research) Sunday March 3rd 2013


166) MEK Inhibitor BAY 86-9766 in Advanced Cancer Patients (Clinical Cancer Research) Sunday March 3rd 2013


167) BRAF Inhibition Facilitates a More Favorable Tumor Microenvironment (Clinical Cancer Research) Sunday March 3rd 2013


168) Plasma MicroRNAs in Ovarian Cancer (Clinical Cancer Research) Sunday March 3rd 2013


169) The Effect of RASSF1A and p63 on Recurrence in NSCLC (Clinical Cancer Research) Sunday March 3rd 2013


170) A 13-Gene Signature Is Prognostic in HPV-Negative OSCC (Clinical Cancer Research) Sunday March 3rd 2013


171) Prognosis and Molecular Profiling of Leiomyosarcomas (Clinical Cancer Research) Sunday March 3rd 2013


172) mTOR in Meningiomas (Clinical Cancer Research) Sunday March 3rd 2013


173) Downregulation of Tristetraprolin Promotes Invasion in HNSCC (Clinical Cancer Research) Sunday March 3rd 2013


174) Hydrolysis of the Prodrug of Gemcitabine, LY2334737 (Clinical Cancer Research) Sunday March 3rd 2013


175) Cross-Presentation of Human Tumor Antigen by pDC (Clinical Cancer Research) Sunday March 3rd 2013


176) Cancer Cell Line Isolating Tools (Clinical Cancer Research) Sunday March 3rd 2013


177) GA201: A Novel Humanized and Glycoengineered Anti-EGFR Antibody (Clinical Cancer Research) Sunday March 3rd 2013


178) Polyphenon E Inhibits Myeloid Suppressor Cells in Neuroblastoma (Clinical Cancer Research) Sunday March 3rd 2013


179) PI3K Inhibition in Lymphoma (Clinical Cancer Research) Sunday March 3rd 2013


180) Low ER-{alpha} Associates with EMT and PI3K Alterations in Endometrial Carcinoma (Clinical Cancer Research) Sunday March 3rd 2013


181) miR-138 Functions as a Tumor Suppressor (Clinical Cancer Research) Sunday March 3rd 2013


182) ZEB1 Regulation of the uPA/PAI-1 System (Clinical Cancer Research) Sunday March 3rd 2013


183) Metastatic Dormancy Monte Carlo Simulation (Clinical Cancer Research) Sunday March 3rd 2013


184) Tumor-Targeted Costimulation with Bispecific Aptamers (Clinical Cancer Research) Sunday March 3rd 2013


185) Agonist mAb Costimulation and the TNFR Family (Clinical Cancer Research) Sunday March 3rd 2013


186) Agonistic CD40 Antibodies for Cancer Therapy (Clinical Cancer Research) Sunday March 3rd 2013


187) Review of PD-1/PD-1 Ligand Pathway Blockade in Cancer Treatment (Clinical Cancer Research) Sunday March 3rd 2013


188) Biomarkers in Immunostimulatory Combination Strategies (Clinical Cancer Research) Sunday March 3rd 2013


189) Immunostimulatory Antibodies and Their Combination (Clinical Cancer Research) Sunday March 3rd 2013


190) Waking the Immune System at Last (Clinical Cancer Research) Sunday March 3rd 2013


191) MGUS and Smoldering Multiple Myeloma (Clinical Cancer Research) Sunday March 3rd 2013


192) Targeting PARP (Clinical Cancer Research) Sunday March 3rd 2013


193) PFS Surrogacy in Chemotherapy and Targeted Agent mCRC Trials (Clinical Cancer Research) Sunday March 3rd 2013


194) New Treatment in Ovarian Cancer (Clinical Cancer Research) Sunday March 3rd 2013


195) EGFR-Targeted Immunotherapy (Clinical Cancer Research) Sunday March 3rd 2013


196) Polyphenol E Reverses MDSC (Clinical Cancer Research) Sunday March 3rd 2013


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

- Fluorescence Anion Sensors
ChemViews Magazine Home RSS

- “Get a job, Ken!” Part 6: Phone and On-site Interviews
Chemistry Blog

- A Closer Look at Radical Migration
ChemViews Magazine Home RSS

- Hey, that's not the right data!
Chemjobber

- Mote learning
Babbage

- Man, I want to go to China someday to give a talk
Chemjobber

- This Week on CENtral Science: #Rarediseases, 80s Nostalgia, #Chemclub, and more
C&ENtral Science

- The microbiological minefield
Babbage

- Archaeology’s Hidden Secrets
Chemical & Engineering News: Latest News

- Hydrogel Implants Slip Past Immune Defenses
Chemical & Engineering News: Latest News

- Somewhere between on and off
Babbage

- A Little Ranbaxy Example
In the Pipeline

- North Korean cyber-rattling
Babbage

- Awakening to New Drugs against Sleeping Sickness
ChemViews Magazine Home RSS

- New Route to Catalytic Nanoflowers
ChemViews Magazine Home RSS


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()